Quantification of biological aging in young adults.
Level 3 - non-randomized controlled study
Prospective longitudinal birth cohort study tracking physiological biomarkers over time.
PubMed 26150497 · doi:10.1073/pnas.1506264112
What was done
Researchers evaluated 954 participants from the Dunedin Study birth cohort across three time points spanning their third and fourth decades of life, prior to the onset of typical age-related diseases. They developed and validated two methods to measure biological aging—one cross-sectional and one longitudinal—measuring the pace of coordinated physiological decline across multiple organ systems including pulmonary, periodontal, cardiovascular, renal, hepatic, and immune function.
What was found
Individuals of the same chronological age varied significantly in biological aging rates. Those aging more rapidly exhibited reduced physical capability, cognitive decline, brain aging, poorer self-rated health, and older facial appearance before midlife. The abstract does not provide exact numerical effect sizes, test statistics, or specific biomarker values.
Why it matters
This study demonstrates that multi-organ physiological aging can be reliably measured in young, clinically healthy adults decades before chronic diseases develop. It provides potential surrogate endpoints to evaluate preventative anti-aging interventions early in life.
Limits
The abstract reports no exact numerical values, effect sizes, or confidence intervals. The findings derive from a single birth cohort, limiting immediate generalizability to other geographic or demographic populations. The observational design does not demonstrate whether modifying these biological aging metrics improves clinical disease outcomes.
Cited by
- supports Biological aging measured across multiple physiological biomarkers correlates with perceived facial age in young adults.